Viewing Study NCT02282059


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2026-02-20 @ 6:21 PM
Study NCT ID: NCT02282059
Status: COMPLETED
Last Update Posted: 2024-06-20
First Post: 2014-10-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors
Sponsor: Pfizer
Organization: